Atopix Therapeutics Limited was acquired by Chiesi Farmaceutici S.p.A. in November 2016 (see press release) and as a result the Atopix office in the UK will close on 28th June 2019.

Ongoing activites will be managed by Chiesi and all enquiries should be directed to Chiesi Farmaceutici S.p.A.